Patent Assignment
Reel/Frame 051162/0771
Assignment of Assignor's Interest
Recorded: 2019-12-03
Pages: 6
Assignors
BIRNBAUM, EVA R.
Executed: 2008-09-25
WARNER, BENJAMIN P.
Executed: 2008-09-25
BALDWIN, SHARON M.
Executed: 2008-09-25
BERGER, JENNIFER A.
Executed: 2008-09-25
PETERSON-COURT, LORI J.
Executed: 2008-09-25
HARRIS, MICHAEL N.
Executed: 2008-09-25
MILLER, REBECCA L. E.
Executed: 2008-09-25
Assignee
CALDERA PHARMACEUTICALS, INC.
278 DP ROAD, SUITE D, LOS ALAMOS, NEW MEXICO, 87544
Covered Property
(1)
Method and Apparatus for Measuring Protein Post-Translational Modification
Related Assignments
(10)
Other recorded transfers of the patent in this record — the chain of ownership.
Confirmatory License
Jun 20, 2018
From: CALDERA PHARMACEUTICALS
To: DEFENSE THREAT REDUCTION AGENCY, US DOD
Reel/Frame 046137/0317 →
Security Agreement
Sep 5, 2018
From: ICAGEN, INC.; ICAGEN CORP.; CALDERA DISCOVERY, INC.; XRPRO SCIENCES, INC.
To: PERCEPTIVE CREDIT HOLDINGS II, LP
Reel/Frame 047016/0859 →
Security Agreement
Sep 5, 2018
From: ICAGEN-T, INC.; ICAGEN CORP.; CALDERA DISCOVERY, INC.; XRPRO SCIENCES, INC.
To: PERCEPTIVE CREDIT HOLDINGS II, LP
Reel/Frame 047317/0860 →
Change of Name
Dec 3, 2019
From: CALDERA PHARMACEUTICALS. INC
To: XRPRO SCIENCES, INC.
Reel/Frame 051169/0438 →
Change of Name
Dec 3, 2019
From: XRPRO SCIENCES, INC.
To: ICAGEN, INC.
Reel/Frame 051198/0647 →
Release of Security Interest
Apr 3, 2020
From: PERCEPTIVE CREDIT HOLDINGS II, LP
To: ICAGEN, INC.; ICAGEN CORP.; CALDERA DISCOVERY, INC.; XRPRO SCIENCES, INC.
Reel/Frame 052304/0304 →
Release of Security Interest
Apr 3, 2020
From: PERCEPTIVE CREDIT HOLDINGS II, LP
To: ICAGEN-T, INC.; ICAGEN CORP.; CALDERA DISCOVERY, INC.; XRPRO SCIENCES, INC.
Reel/Frame 052304/0712 →
Change of Name
Apr 13, 2021
From: ADJACENT ACQUISITION CO., LLC
To: ICAGEN, LLC
Reel/Frame 055910/0905 →
Assignment of Assignor's Interest
Apr 13, 2021
From: ICAGEN, INC.; ICAGEN CORP.; XRPRO SCIENCES, INC.; CALDERA DISCOVERY, INC.
To: ADJACENT ACQUISITION CO., LLC
Reel/Frame 055903/0125 →
Confirmatory License
Sep 19, 2024
From: CALDERA PHARMACEUTICALS
To: UNITED STATES GOVERNMENT
Reel/Frame 068629/0646 →